Free Trial

Acadia Healthcare (NASDAQ:ACHC) Sets New 52-Week Low - Time to Sell?

Acadia Healthcare logo with Medical background

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report)'s share price hit a new 52-week low on Monday . The stock traded as low as $20.36 and last traded at $20.64, with a volume of 742834 shares. The stock had previously closed at $21.56.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Royal Bank Of Canada dropped their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. KeyCorp dropped their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Stephens raised shares of Acadia Healthcare to a "hold" rating in a report on Monday, June 2nd. Guggenheim assumed coverage on shares of Acadia Healthcare in a report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 target price for the company. Finally, Bank of America dropped their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a report on Friday, February 28th. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $47.94.

Read Our Latest Stock Analysis on ACHC

Acadia Healthcare Price Performance

The firm's 50-day moving average price is $22.86 and its 200-day moving average price is $31.92. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $2.03 billion, a PE ratio of 10.87, a PEG ratio of 3.92 and a beta of 0.94.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.05. The firm had revenue of $770.51 million for the quarter, compared to analysts' expectations of $769.90 million. Acadia Healthcare had a net margin of 5.94% and a return on equity of 8.72%. The business's revenue was up .3% compared to the same quarter last year. During the same period in the prior year, the company earned $0.84 EPS. On average, equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Institutional Trading of Acadia Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Sterling Capital Management LLC raised its position in Acadia Healthcare by 59.1% in the 4th quarter. Sterling Capital Management LLC now owns 5,456 shares of the company's stock worth $216,000 after purchasing an additional 2,026 shares during the period. US Bancorp DE increased its position in shares of Acadia Healthcare by 18.5% during the fourth quarter. US Bancorp DE now owns 15,196 shares of the company's stock worth $603,000 after acquiring an additional 2,374 shares during the period. Raymond James Financial Inc. purchased a new position in shares of Acadia Healthcare during the fourth quarter worth approximately $5,134,000. Russell Investments Group Ltd. increased its position in shares of Acadia Healthcare by 21.4% during the fourth quarter. Russell Investments Group Ltd. now owns 18,421 shares of the company's stock worth $730,000 after acquiring an additional 3,248 shares during the period. Finally, Captrust Financial Advisors increased its position in shares of Acadia Healthcare by 66.5% during the fourth quarter. Captrust Financial Advisors now owns 12,784 shares of the company's stock worth $507,000 after acquiring an additional 5,108 shares during the period.

Acadia Healthcare Company Profile

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Recommended Stories

Should You Invest $1,000 in Acadia Healthcare Right Now?

Before you consider Acadia Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.

While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines